Fresh analysis suggests that people who discontinue popular slimming jabs like Mounjaro or Wegovy tend to recover lost weight much more quickly than those who halt traditional lifestyle regimens.
Research printed in a prominent health publication shows that while obese individuals can lose substantial amounts of their total mass while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month after stopping.
"Individuals buying these treatments must be aware of the potential of rapid rebound weight gain when the therapy concludes," warns lead investigator Dr. Susan Jebb.
This pace of recovery implies a return to pre-treatment weight within about a year and a half.
Weighing Treatments
The research, which looked at dozens of studies involving thousands of patients, contrasted the results of GLP-1 agonists with conventional dieting.
Researchers point out that individuals who shed pounds through lifestyle changes alone generally have a slower creep back—perhaps 100 grams monthly—post-intervention.
Understanding the Quick Regain
Doctors propose the way of the injections accounts for the heightened weight return.
GLP-1 drugs mimic a natural hormone called GLP-1, which moderates feelings of fullness.
"Sustained high doses of GLP-1 levels several times higher than normal may cause the system to generate a reduced amount of its own natural hormone, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this hormone supplement means appetite is no longer kept in check, making overeating much more probable."
An Ongoing Disease?
Medical guidelines advise the injections for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.
Many experts contend that, considering the likelihood of weight regain, the therapy should be considered long-term.
This view is reinforced by drug manufacturers, who note that the results "highlight the chronic character of excess weight," similar to managing conditions like diabetes.
Patient Accounts
Users who have discontinued the medication describe a powerful return of hunger.
"It felt as if a switch activating and I was suddenly ravenous," said a patient.
The struggle is exacerbated if users have not established permanent dietary or behavioural changes during treatment.
Significant Interest
Survey data show that millions of people in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.
- Use is higher among women than men.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion access the drugs through private healthcare rather than the NHS.
In conclusion, experts stress that while these medications are effective agents for shedding pounds, they are not a standalone fix and long-term success relies on combined lifestyle support.
